|
Zydus Lifesciences Limited is a leading Indian Pharmaceutical company that offers healthcare services globally. The company manufactures formulations, APIs, vaccines, biosimilars, complex products (transdermals, topical etc.), animal health products as well as wellness products.
Zydus Lifesciences Limited has more than 30 manufacturing plants worldwide including India, Germany, Brazil & USA. Zydus Lifesciences Limited is the fourth largest pharmaceutical company in India. Zydus Lifesciences was formerly known as Cadila Healthcare Limited.
Issue Period | Jun 23, 2022 - Jul 6, 2022 |
Security Name | Zydus Lifesciences Limited |
Issue Type | Tender Offer |
Issue Size (Shares) | 1.15 Crores |
Issue Size (Amount) | ₹750.00 Crores |
Buyback Price | ₹650 per share |
Face Value | ₹1 per share |
Listing At | BSE, NSE |
Offer Opens On | Jun 23, 2022 |
Offer Closes On | Jul 6, 2022 |
Record Date | Jun 2, 2022 |
Last Date for receipt of Tender Forms | Jul 6, 2022 |
Finalisation of Buyback Acceptance | Jul 14, 2022 |
Last Date for settlment of bids | Jul 15, 2022 |
Last Date for Extinguishment of Shares | Jul 22, 2022 |
Category | Entitlement Ratio of Buyback |
---|---|
Reserved Category for Small Shareholders | 26 Equity Share out of every 503 Fully paid-up Equity Shares held on the Record Date. |
General Category for all other Eligible Shareholders | 1 Equity Shares out of every 101 Fully paid-up Equity Shares held on the Record Date. |
Particulars | For the year/period ended (Rs. in Million) | ||
---|---|---|---|
31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
Total Income | 1,54,899 | 1,51,394 | 1,43,670 |
Profit After Tax | 23,726 | 21,850 | 12,044 |
Net Worth | 1,69,996 | 1,29,923 | 1,03,757 |
Month | High Price | Low Price | Average Price |
---|---|---|---|
Apr-2022 | 376.6 | 337.7 | 359.37 |
Mar-2022 | 379 | 331 | 359.62 |
Feb-2022 | 420.5 | 343 | 385.95 |
Month | High Price | Low Price | Average Price |
---|---|---|---|
Apr-2022 | 376.7 | 337.55 | 359.43 |
Mar-2022 | 378.6 | 331.55 | 359.63 |
Feb-2022 | 420.55 | 342.85 | 385.99 |
The buyback is being undertaken for the following reason:
1. The Buyback will help the Company to distribute a part of the surplus cash to its shareholders holding Equity Shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in longer term and improving the return on equity.
Sorry, we couldn't find any reviews, please check back later.
Zydus Lifesciences Limited
Zydus Corporate Park, Scheme No. 63,
Khoraj (Gandhinagar), 536, Sarkhej-Gandhinagar Hwy
Near Vaishnodevi Circle, Ahmedabad, 382481
Phone: +91-79-71800000
Email: dhavalsoni@zyduslife.com
Website: https://www.zyduslife.com/index
Link Intime India Private Ltd
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: zyduslife.buyback2022@linkintime.co.in
Website: https://linkintime.co.in/
Lead Manager(s)
Registered Broker
|